Based in the Primary Care Research Unit at the University of Cambridge, Margaret has been passionately involved as a patient,carer and lay representative in cancer services and research since 1997. She is the Patient and Public Involvement (PPI) lead for CanTest and has supported the programme from its inception. As well as bringing expertise in PPI to the delivery of the programme, she leads a PPI stakeholder group who help shape the research agenda, as well as supporting the design and delivery of studies.
University of Cambridge, UK
Patient and Public Involvement (PPI) in palliative/end of life care and early cancer diagnosis.
- Tests and tools for the detection of ovarian cancer in primary care
- Establishing acceptability and outcomes for faecal immunochemical tests (FITs) in the English primary care symptomatic population: a mixed-methods study in the East of England
- CanImpact: the impact of the COVID-19 pandemic on cancer detection in primary care
- Understanding and implementing artificial intelligence technologies to improve skin cancer assessment in primary care settings
- Understanding missed diagnostic opportunities in bladder and kidney cancer
- Walter FM, Penfold C, Joannides A, Saji S, Johnson M, Watts C, Brodbelt A, Jenkinson MD, Price SJ, Hamilton W, Scott SE. Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences. Br J Gen Pract, 2019, bjgp19X701861. DOI: 10.3399/bjgp19X70186
- Walter FM, Thompson MJ, Wellwood I, Abel GA, Hamilton W, Johnson M, Lyratzopoulos G, Messenger MP, Neal RD, Rubin G, Singh H, Spencer A, Sutton S, Vedsted P, Emery JD. Evaluating diagnostic strategies for early detection of cancer: the CanTest framework. BMC Cancer, 2019, 19:586